You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The SBIR grant will support the development of the firm's single-cell analysis platform, Tapestri.
The firm's microfluidic based technology collects and purifies genetic material, producing a complete PCR reaction to identify pathogens in liquid samples.
The firm will use the proceeds to develop its cell-sorting technology for cell line development, genomic sample preparation, CRISPR gene editing, and antibody discovery.
Hangzhou Chengyuan Genomics will provide single-cell analysis services and sell 1CellBio's InDrop instrument, reagents, and kits in China.
The system uses microfluidics and real-time image analysis to isolate single cells and provide visual documentation of monoclonality.
The device allows researchers to track cancer growth for a longer period of time, enabling improved observations and analysis, according to the researchers.
Ascendas will develop and commercialize molecular diagnostic systems and assays using certain of Fluidigm's microfluidic technologies.
Based in Beverly, Massachusetts, the biotechnology company aims to have the pathogen detection technology on the market by the end of 2018.
New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.
The Bay Area firm is planning to launch a low-cost, microfluidics-based infectious disease diagnostic called the Simple Chip in the next few years.
Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.
Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.
A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.
In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.